Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-9158
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives ; volume:9 ; number:1 ; day:7 ; month:5 ; year:2020 ; pages:1-11 ; date:12.2020
Translational neurodegeneration ; 9, Heft 1 (7.5.2020), 1-11, 12.2020
- Creator
-
Cheng, Yuan
Tian, Ding-Yuan
Wang, Yan-Jiang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-020-00195-1
- URN
-
urn:nbn:de:101:1-2020071419443431908714
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cheng, Yuan
- Tian, Ding-Yuan
- Wang, Yan-Jiang
- SpringerLink (Online service)
Other Objects (12)
Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation